Basit öğe kaydını göster

dc.contributor.authorAltun, H.
dc.contributor.authorKurutaş, E.B.
dc.contributor.authorŞahin, N.
dc.contributor.authorGöngör, O.
dc.contributor.authorFindikli, E.
dc.date.accessioned2020-11-20T17:17:18Z
dc.date.available2020-11-20T17:17:18Z
dc.date.issued2018
dc.identifier.issn1738-1088
dc.identifier.urihttps://doi.org/10.9758/cpn.2018.16.1.383
dc.identifier.urihttps://hdl.handle.net/20.500.12809/6367
dc.description.abstractObjective: Autism spectrum disorder (ASD) is a complex neurodevelopmental syndrome with an increasingly prevalent etiology, yet not fully understood. It has been thought that Vitamin D, complex B vitamin levels and homocysteine are associated with environmental factors and are important in ASD. The aim of this study was to examine serum Vitamin D, Vitamin D receptor (VDR), homocysteine, vitamin B6, vitamin B12 and folate levels in ASD. Methods: In this study, serum Vitamin D and VDR, homocysteine, vitamins B6, B12 and folate levels were determined in 60 patients with ASD (aged 3 to 12 years) and in 45 age-gender matched healthy controls. In addition, calcium, phosphorus and alkaline phosphatase, which are associated with Vitamin D metabolism, were measured from serum in both groups. ASD severity was evaluted by the Childhood Autism Rating Scale (CARS). Results: Serum Vitamin D and VDR were substantially reduced in patients with ASD in comparision to control group. However, homocysteine level was significantly higher and vitamin B6, vitamin B12 and folate were also reduced in patients with ASD. Total CARS score showed a positive association with homocysteine and a negative correlation with vitamins D,B6, B12, folate and VDR. Conclusion: This comprehensive study, which examines many parameters has shown that low serum levels of vitamins D, B6, B12, folate and VDR as well as high homocysteine are important in the etiopathogenesis of ASD. However, further studies are required to define the precise mechanism(s) of these parameters and their contributions to the etiology and treatment of ASD. Copyright © 2018, Korean College of Neuropsychopharmacology.en_US
dc.description.sponsorship2014/3-49Men_US
dc.description.sponsorshipThis study was supported by Kahramanmaras Sutcu Imam University Research Foundation (2014/3-49M). The authors wish to thank the patients and families who participated in this study.en_US
dc.item-language.isoengen_US
dc.publisherKorean College of Neuropsychopharmacologyen_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAutism spectrum disorderen_US
dc.subjectComplex B vitamin.en_US
dc.subjectHomocysteineen_US
dc.subjectVitamin Den_US
dc.subjectVitamin D receptoren_US
dc.titleThe levels of Vitamin D, Vitamin D receptor, homocysteine and complex B Vitamin in children with autism spectrum disordersen_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTempAltun, H., Departments of Child and Adolescent Psychiatry, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Bati Çevreyolu Bulv., 251/A Onikişubat, Kahramanmaraş, 46040, Turkey; Kurutaş, E.B., Departments of Biochemistry, South Korea; Şahin, N., Department of Child and Adolescent Psychiatry, Faculty of Medicine, Muğla Sitki Koçman University, Muğla, Turkey; Göngör, O., Departments of Pediatric Neurology, South Korea; Findikli, E., Departments of Psychiatry, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkeyen_US
dc.identifier.doi10.9758/cpn.2018.16.1.383
dc.identifier.volume16en_US
dc.identifier.issue4en_US
dc.identifier.startpage383en_US
dc.identifier.endpage390en_US
dc.relation.journalClinical Psychopharmacology and Neuroscienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster